news & events

Check out what we’ve been up to and where we can connect!


Baricitinib + remdesivir superior to remdesivir alone for hospitalized adults with COVID-19: ACTT-2 results published in NEJM

April 24, 2021
Results of the Adaptive COVID-19 Treatment Trial (ACTT)-2 investigating combination treatment with baricitinib, a Janus kinase inhibitor, and remdesivir for the treatment of COVID-19 in hospitalized adults were published in the New England Journal of Medicine (NEJM) on March 4, 2021, showing that the combination treatment was superior to remdesivir alone.

Read more »


World Vaccine Congress Washington 2022

April 18-21, 2022
Attending the World Vaccine Congress 2022? Stop by our booth for a presentation about COVID-19 vaccine development, conducting trials in sub-Saharan Africa or using novel methods to ensure equitable access to clinical research. Members of our team will also be available to talk about our capabilities and services.

Read more »

2022 WAC-CREP conference

March 17-19, 2022
At the 5th annual WAC-CREP conference, FHI Clinical employees are presenting findings from research being conducted within the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network.

Read more »